By Professor John Philip Chalmers

Journal articles

Rahimi K; Canoy D; Nazarzadeh M; Salimi-Khorshidi G; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Chalmers J; Perkovic V; Sundstorm J, 2019, 'Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)', BMJ Open, 9, pp. e028698, http://dx.doi.org/10.1136/bmjopen-2018-028698

Pikkemaat M; Andersson T; Melander O; Chalmers J; Rådholm K; Bengtsson Boström K, 2019, 'C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register', Diabetes Research and Clinical Practice, 150, pp. 174 - 183, http://dx.doi.org/10.1016/j.diabres.2019.03.014

Zhang Z; Tremblay J; Raelson J; Sofer T; Du L; Fang Q; Argos M; Marois-Blanchet FC; Wang Y; Yan L; Chalmers J; Woodward M; Harrap S; Hamet P; Luo H; Wu J, 2019, 'EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes', Journal of Hypertension, 37, pp. 775 - 789, http://dx.doi.org/10.1097/HJH.0000000000001948

Harrap SB; Lung T; Chalmers J, 2019, 'New Blood Pressure Guidelines Pose Difficult Choices for Australian Physicians', Circulation Research, 124, pp. 975 - 977, http://dx.doi.org/10.1161/CIRCRESAHA.118.314637

Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Martins SO; Olavarria VV; Levi C; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG; Kim JS; Stapf C; Simes RJ; Hankey GJ; Sandercock P; Bousser MG; Wong KSL; Scaria A; Hirakawa Y; Moullaali TJ; Carcel C; Gordon P; Fuentes-Patarroyo SX; Benito D; Chen R; Cao Y; Kunchok A; Winters S; Coutts S; Yoshimura S; You S; Yang J; Wu G; Zhang S; Manning L; Mistri A; Haunton V; Minhas J; Malavera A; Lim J; Liu L; Kumar NN; Tay N; Jenson K; Richtering S; Tucker S; Knight E; Ivanova E; Thembani E; Odgers E; Sanders E; Small S; Vaghasiya R; Armenis M; Donnelly P; Baig MA; Blacklock N; Naidu B; Monaghan H; Smith P; Glass P; Bai X; Li Q; Zhu P; Kong L; He R; Zhao H; Lv J; Jia H; Xi Z; Cong Y; Cui B; Deng H; Guo Y; He L, 2019, 'Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial', The Lancet, 393, pp. 877 - 888, http://dx.doi.org/10.1016/S0140-6736(19)30038-8

Robinson TG; Wang X; Durham AC; Ford GA; Liao J; Littlewood S; Roffe C; White P; Chalmers J; Anderson CS, 2019, 'The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: The impact of enhanced research infrastructure on trial metrics and patient outcomes', Health Research Policy and Systems, 17, pp. 19, http://dx.doi.org/10.1186/s12961-019-0417-2

Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT; Appel LJ; Greene T; Chen TK; Chalmers J; Arima H; Perkovic V; Levin A; Djurdjev O; Tang M; Nally J; Navaneethan SD; Schold JD; Weldegiorgis M; Herrington WG; Smith M; Hsu CY; Hwang SJ; Chang AR; Kirchner HL; Green JA; Ho K; Marks A; Prescott G; Clark LE; Fluck N; Shalev V; Chodick G; Blankestijn PJ; Van Zuilen A; Van den Brand JA; Sarnak MJ; Bottinger E; Nadkarni GN; Ellis SG; Nadukuru R; Metzger M; Flamant M; Houillier P; Haymann JP; Froissart M; Kenealy T; Elley RC; Collins JF; Drury PL; Cuddeback JK; Ciemins EL; Stempniewicz R; Nelson RG; Knowler WC; Bakker SJ; Major RW; Medcalf JF; Shepherd D; Barrett-Connor E; Bergstrom J; Ix JH; Molnar MZ; Sumida K; de Zeeuw D; Brenner B; Qureshi AR; Elinder CG; Runesson B; Evans M; Segelmark M; Stendahl M; Schön S; Naimark DM; Tangri N, 2019, 'Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies', The Lancet Diabetes and Endocrinology, 7, pp. 115 - 127, http://dx.doi.org/10.1016/S2213-8587(18)30313-9

Santo K; Singleton A; Rogers K; Thiagalingam A; Chalmers J; Chow CK; Redfern J, 2019, 'Medication reminder applications to improve adherence in coronary heart disease: A randomised clinical trial', Heart, 105, pp. 323 - 329, http://dx.doi.org/10.1136/heartjnl-2018-313479

Inker LA; Grams ME; Levey AS; Coresh J; Cirillo M; Collins JF; Gansevoort RT; Gutierrez OM; Hamano T; Heine GH; Ishikawa S; Jee SH; Kronenberg F; Landray MJ; Miura K; Nadkarni GN; Peralta CA; Rothenbacher D; Schaeffner E; Sedaghat S; Shlipak MG; Zhang L; van Zuilen AD; Hallan SI; Kovesdy CP; Woodward M; Levin A; Astor B; Appel L; Greene T; Chen T; Chalmers J; Arima H; Perkovic V; Yatsuya H; Tamakoshi K; Li Y; Hirakawa Y; Matsushita K; Sang Y; Polkinghorne K; Chadban S; Atkins R; Djurdjev O; Liu L; Zhao M; Wang F; Wang J; Ebert N; Martus P; Tang M; Emrich I; Seiler S; Zawada A; Nally J; Navaneethan S; Schold J; Sarnak M; Katz R; Hiramoto J; Iso H; Yamagishi K; Umesawa M; Muraki I; Fukagawa M; Maruyama S; Hasegawa T; Fujii N; Wheeler D; Emberson J; Townend J; Brenner H; Schöttker B; Saum KU; Fox C; Hwang SJ; Köttgen A; Schneider MP; Eckardt KU; Green J; Kirchner HL; Chang AR; Ho K; Ito S; Miyazaki M; Nakayama M; Yamada G; Irie F; Sairenchi T; Yano Y; Kotani K; Nakamura T; Kimm H; Mok Y; Chodick G; Shalev V; Wetzels JFM; Blankestijn PJ; van den Brand J; Kollerits B, 2019, 'Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium', American Journal of Kidney Diseases, 73, pp. 206 - 217, http://dx.doi.org/10.1053/j.ajkd.2018.08.013

Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson A-M; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN, 2019, 'Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.', European Heart Journal, 40, pp. 2899 - 2906, http://dx.doi.org/10.1093/eurheartj/ehy839

Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060

Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M; Chalmers J; Perkovic V, 2019, 'Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium', BMJ (Online), 364, pp. k5301, http://dx.doi.org/10.1136/bmj.k5301

Delcourt C; Carcel C; Zheng D; Sato S; Arima H; Bhaskar S; Janin P; Al-Shahi Salman R; Cao Y; Zhang S; Heeley E; Davies L; Chalmers J; Anderson CS, 2019, 'Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study', Cerebrovascular Diseases Extra, 9, pp. 148 - 154, http://dx.doi.org/10.1159/000504531

You S; Zheng D; Delcourt C; Sato S; Cao Y; Zhang S; Yang J; Wang X; Lindley RI; Robinson T; Anderson CS; Chalmers J, 2019, 'Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage: The INTERACT-2 Study', Stroke, 50, pp. 1409 - 1414, http://dx.doi.org/10.1161/STROKEAHA.118.024403

Salam A; Atkins E; Sundström J; Hirakawa Y; Ettehad D; Emdin C; Neal B; Woodward M; Chalmers J; Berge E; Yusuf S; Rahimi K; Rodgers A, 2019, 'Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: A systematic review of randomized trials', Journal of Hypertension, 37, pp. 16 - 23, http://dx.doi.org/10.1097/HJH.0000000000001994

Ohkuma T; Zoungas S; Jun M; Lisheng L; Mancia G; Marre M; Rodgers A; Williams B; Woodward M; Chalmers J, 2019, 'Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial', Diabetes, Obesity and Metabolism, 22, pp. 452 - 457, http://dx.doi.org/10.1111/dom.13878

Chen X; Anderson CS; Wang X; Robinson T; Lavados PM; Lindley RI; Chalmers J; Delcourt C, 2019, 'Abstract TP362: Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.tp362

Wang X; Moullaali T; Sandset EC; Berge E; Robinson T; Lindley R; Zheng D; Delcourt C; Arima H; Song L; Chalmers J; Anderson C, 2019, 'Abstract TP371: Adopting a Patient-centered Approach in Acute Stroke Trials With Utility-weighted Modified Rankin Scale Scores', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.tp371

Yoshimura S; Carcel C; Delcourt C; Wang X; Torii-Yoshimura T; Lindley RI; Chalmers J; Anderson CS, 2019, 'Abstract WP107: Early Recurrence of Ischemic Stroke in Alteplase-treated Patients: The ENCHANTED Study', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.wp107

Tremblay J; Haloui M; Harvey F; Tahir R; Marois-Blanchet F-C; Long C; Attaoua R; Simon P; Santucci L; Hizel C; Chalmers J; Marre M; Harrap S; Cifkova R; Krajcoviechova A; Matthews D; Williams B; Poulter N; Zoungas S; Colagiuri S; Mancia G; Grobbee DE; Rodgers A; Liu L; Agbessi M; Bruat V; Favé M-J; Harwood M; Awadalla P; Woodward M; Hamet P, 2019, 'Polygenic risk scores predict diabetic complications and their response to therapy', , http://dx.doi.org/10.1101/19010785

OSHIMA M; Jun M; Toyama T; Perkovic V; Chalmers J; Woodward M, 2019, 'SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES', Kidney International Reports, 4, pp. S128 - S128, http://dx.doi.org/10.1016/j.ekir.2019.05.325

JUN M; Ohkuma T; Woodward M; Chalmers J; Zoungas S, 2019, 'SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS', Kidney International Reports, 4, pp. S131 - S131, http://dx.doi.org/10.1016/j.ekir.2019.05.334

Mohammedi K; Chalmers J; Herrington W; Li Q; Mancia G; Marre M; Poulter N; Rodgers A; Williams B; Perkovic V; Coresh J; Woodward M, 2018, 'Associations between body mass index and the risk of renal events in patients with type 2 diabetes', Nutrition and Diabetes, 8, pp. 7, http://dx.doi.org/10.1038/s41387-017-0012-y

Yoshimura S; Lindley RI; Carcel C; Sato S; Delcourt C; Wang X; Chalmers J; Anderson CS; Billot L; Woodward M, 2018, 'NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke', Neurology, 91, pp. E1695 - E1701, http://dx.doi.org/10.1212/WNL.0000000000006437

Anderson CS; Woodward M; Arima H; Chen X; Lindley RI; Wang X; Chalmers J; Robinson TG, 2018, 'Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.', International Journal of Stroke, pp. 1 - 4, http://dx.doi.org/10.1177/1747493018806170

Carcel C; Neal B; Oparil S; Narkiewicz K; Wang J; Schiffrin E; Azizi M; Poulter N; Chalmers J, 2018, 'A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region', Journal of Hypertension, 36, pp. e306, http://dx.doi.org/10.1097/01.hjh.0000549252.23988.4b

Wang X; Sandset E; Carcel C; Chalmers J; Anderson C, 2018, 'PREDICTORS OF SEVERITY OF HYPERTENSIVE RESPONSE IN ACUTE INTRACEREBRAL HAEMORRHAGE', JOURNAL OF HYPERTENSION, 36, pp. E323 - E323, http://dx.doi.org/10.1097/01.hjh.0000549321.17364.3c

Mundra PA; Barlow CK; Nestel PJ; Barnes EH; Kirby A; Thompson P; Sullivan DR; Alshehry ZH; Mellett NA; Huynh K; Jayawardana KS; Giles C; McConville MJ; Zoungas S; Hillis GS; Chalmers J; Woodward M; Wong G; Kingwell BA; Simes J; Tonkin AM; Meikle PJ, 2018, 'Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention', JCI insight, 3, http://dx.doi.org/10.1172/jci.insight.121326

Santo K; Singleton A; Rogers K; Thiagalingam A; Chalmers J; Chow C; Redfern J, 2018, '1109Medication reminder apps to improve medication adherence in coronary heart disease patients (MedApp-CHD): a randomised clinical trial', European Heart Journal, 39, http://dx.doi.org/10.1093/eurheartj/ehy565.1109

Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG, 2018, 'Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial', Cerebrovascular Diseases, 45, pp. 213 - 220, http://dx.doi.org/10.1159/000488911

Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M, 2018, 'Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study', Diabetes, Obesity and Metabolism, 20, pp. 1903 - 1910, http://dx.doi.org/10.1111/dom.13311

Welsh P; Rankin N; Li Q; Mark PB; Würtz P; Ala-Korpela M; Marre M; Poulter N; Hamet P; Chalmers J; Woodward M; Sattar N, 2018, 'Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial', Diabetologia, 61, pp. 1581 - 1591, http://dx.doi.org/10.1007/s00125-018-4619-x

HAMET P; HARVEY F; HALOUI M; WOODWARD M; TAHIR R; MAROIS-BLANCHET F-C; LONG C; MARRE M; HARRAP S; CHALMERS J; TREMBLAY J, 2018, 'Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications', Diabetes, 67, http://dx.doi.org/10.2337/db18-210-lb

Thomas MC; Woodward M; Li Q; Pickering R; Tikellis C; Poulter N; Cooper ME; Marre M; Zoungas S; Chalmers J, 2018, 'Relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes mellitus: Results from the ADVANCE trial', Journal of the American Heart Association, 7, pp. e008226, http://dx.doi.org/10.1161/JAHA.117.008226

Santo K; Hyun K; de Keizer L; Thiagalingam A; Hillis GS; Chalmers J; Redfern J; Chow CK, 2018, 'The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: An analysis of the TEXT ME study', International Journal of Behavioral Nutrition and Physical Activity, 15, pp. 45, http://dx.doi.org/10.1186/s12966-018-0677-1

Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME, 2018, 'Serumpotassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortiummeta-analysis', EUROPEAN HEART JOURNAL, 39, pp. 1535 - +, http://dx.doi.org/10.1093/eurheartj/ehy100

Chen G; Wang X; Robinson TG; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS, 2018, 'Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial', Journal of the Neurological Sciences, 387, pp. 1 - 5, http://dx.doi.org/10.1016/j.jns.2018.01.014

Anderson CS; Woodward M; Chalmers J, 2018, 'More on low-dose versus standard-dose intravenous alteplase in acute ischemic stroke', New England Journal of Medicine, 378, pp. 1465 - 1466, http://dx.doi.org/10.1056/NEJMc1801548

van Steen SC; Woodward M; Chalmers J; Li Q; Marre M; Cooper ME; Hamet P; Mancia G; Colagiuri S; Williams B; Grobbee DE; DeVries JH, 2018, 'Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial', Diabetologia, 61, pp. 780 - 789, http://dx.doi.org/10.1007/s00125-017-4539-1

Karmali KN; Lloyd-Jones DM; van der Leeuw J; Goff DC; Yusuf S; Zanchetti A; Glasziou P; Jackson R; Woodward M; Rodgers A; Neal BC; Berge E; Teo K; Davis BR; Chalmers J; Pepine C; Rahimi K; Sundström J, 2018, 'Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data', PLoS Medicine, 15, pp. e1002538, http://dx.doi.org/10.1371/journal.pmed.1002538

Ohkuma T; Woodward M; Chalmers J, 2018, 'Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: The ADVANCE trial. Diabetes care 2017;40:1203-1209', Diabetes Care, 41, pp. e39, http://dx.doi.org/10.2337/dci17-0060

Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK, 2018, 'Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review', Stroke and Vascular Neurology, 3, pp. 28 - 33, http://dx.doi.org/10.1136/svn-2017-000112

Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M, 2018, 'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Care, 41, pp. 163 - 170, http://dx.doi.org/10.2337/dc17-1467

Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS, 2018, 'Clinical utility of electronic Alberta stroke program early computed tomography score software in the ENCHANTED trial database', Stroke, 49, pp. 1407 - 1411, http://dx.doi.org/10.1161/STROKEAHA.117.019863

Kim JS; Kim YJ; Lee KB; Cha JK; Park JM; Hwang Y; Kim EG; Rha JH; Koo J; Kim J; Kim YJ; Seo WK; Kim DE; Robinson TG; Lindley RI; Wang X; Chalmers J; Anderson CS, 2018, 'Low- versus standard-dose intravenous alteplase in the context of bridging therapy for acute ischemic stroke: A Korean ENCHANTED study', Journal of Stroke, 20, pp. 131 - 139, http://dx.doi.org/10.5853/jos.2017.01578

Nowson C; Lim K; Land MA; Webster J; Shaw JE; Chalmers J; Flood V; Woodward M; Grimes C, 2018, 'Salt intake and dietary sources of salt on weekdays and weekend days in Australian adults', Public Health Nutrition, 21, pp. 2174 - 2182, http://dx.doi.org/10.1017/S1368980017004104

Bermingham ML; Colombo M; McGurnaghan SJ; Blackbourn LAK; Vučković F; Pučić Baković M; Trbojević-Akmačić I; Lauc G; Agakov F; Agakova AS; Hayward C; Klarić L; Palmer CNA; Petrie JR; Chalmers J; Collier A; Green F; Lindsay RS; Macrury S; McKnight JA; Patrick AW; Thekkepat S; Gornik O; McKeigue PM; Colhoun HM; SDRN Type 1 Bioresource Investigators , 2018, 'N-Glycan Profile and Kidney Disease in Type 1 Diabetes.', Diabetes Care, 41, pp. 79 - 87, http://dx.doi.org/10.2337/dc17-1042

Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R, 2017, 'Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk', Health Policy, 121, pp. 1233 - 1239, http://dx.doi.org/10.1016/j.healthpol.2017.09.022

You S; Wang X; Lindley RI; Robinson T; Anderson CS; Cao Y; Chalmers J, 2017, 'Early Cognitive Impairment after Intracerebral Hemorrhage in the INTERACT1 Study', Cerebrovascular Diseases, 44, pp. 320 - 324, http://dx.doi.org/10.1159/000481443

Yang J; Wang X; Yu JP; Hang J; Lavados P; Robinson T; Arima H; Lindley RI; Anderson CS; Chalmers J, 2017, 'Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time', Scientific Reports, 7, pp. 14168, http://dx.doi.org/10.1038/s41598-017-14164-8

Back to profile page